| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |